James Patch currently serves as Director at Pfizer, a position held since December 2023 following the acquisition of Seagen. Prior to this, James held the role of Director at Seagen from April 2020 to December 2023, leading the Purification Process Development group for therapeutic proteins and antibody-drug conjugates while also serving as a part-time CMC leader. James's career includes significant experience at Genentech as Associate Director and Principal Engineer, focusing on late-stage downstream bioprocess development and mechanistic chromatography modeling. Earlier in the career at Pfizer, from January 2005 to February 2012, James worked as a Sr. Engineer in Purification Development, specializing in early-phase bioprocess development within Vaccines R&D, and previously within Wyeth before 2009. James earned a Ph.D. in Chemical and Biological Engineering from Northwestern University and holds a Bachelor of Engineering from the same institution, with additional studies at Duke University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices